Primary Biliary Cholangitis Treatment: What Works in 2026
Primary Biliary Cholangitis (PBC) treatment has changed dramatically since 2025. With Ocaliva withdrawn and seladelpar and elafibranor now approved, patients have better options than ever. Learn what works, what doesn’t, and how to navigate your care in 2026.